Copyright
©The Author(s) 2022.
World J Immunol. Jan 24, 2022; 12(1): 1-8
Published online Jan 24, 2022. doi: 10.5411/wji.v12.i1.1
Published online Jan 24, 2022. doi: 10.5411/wji.v12.i1.1
Table 4 Tumor necrosis factor superfamily co-stimulatory molecules studied in various diseases
| Molecule | Disease | Alteration | Ref. |
| CD27 | Lupus erythematosus | Increased expression in plasmablasts | [21] |
| CD70 | Lupus erythematosus | Increased expression in plasmablasts | [21] |
| CD40 | Hyper IgM Syndrome | Mutations | [22] |
| CD30 | Vernal Keratoconjunctivitis | Increased expression in T cells | [23] |
| CD267 | Common variable immunodeficiency | Mutations | [24] |
- Citation: Velazquez-Soto H, Real F, Jiménez-Martínez MC. Historical evolution, overview, and therapeutic manipulation of co-stimulatory molecules. World J Immunol 2022; 12(1): 1-8
- URL: https://www.wjgnet.com/2219-2824/full/v12/i1/1.htm
- DOI: https://dx.doi.org/10.5411/wji.v12.i1.1